Cure8 research brief
Robotic ileocecal resection using the Hugo RAS system may offer a feasible surgical option for terminal ileal Crohn's disease with favorable short-term perioperative outcomes in this small initial series.
Surgeons, surgical teams, adult Crohn's patients considering ileocecal resection, and clinicians managing postoperative follow-up or recurrence.
This is a retrospective case series of 7 consecutive patients who underwent fully robotic ileocecal resection with the Hugo RAS system between December 2024 and January 2026.
The authors report median operative time (235 minutes), no conversions to open or laparoscopic surgery, no intraoperative complications or transfusions, two postoperative complications, and no mortality. At a mean 11-month follow-up, two patients had endoscopic recurrence but none had clinical recurrence.
The study is an initial, small series and the authors call for larger studies with longer follow-up to confirm safety and long-term outcomes.
Small retrospective case series (7 patients) with short follow-up (mean 11 months); findings are preliminary and need confirmation in larger, comparative studies.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
People with Crohn’s disease who need a repeat ileocolic resection may wonder whether laparoscopic surgery is a good option. This study suggests laparoscopic attempts are often successful, and if conversion is needed...
Surgery is common in Crohn’s disease and different types of resections carry different short-term risks.
Surgical removal of the disease-affected ileocecal segment is common in Crohn’s disease; this study provides regional evidence that laparoscopic ICR can be safe and offers faster recovery compared with open surgery.
